GENFIT (GNFT)
(Delayed Data from NSDQ)
$4.15 USD
-0.06 (-1.31%)
Updated Jul 24, 2024 03:59 PM ET
After-Market: $4.16 +0.01 (0.24%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
GNFT 4.15 -0.06(-1.31%)
Will GNFT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GNFT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GNFT
GENFIT S.A. Unsponsored ADR (GNFT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
GNFT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GNFT
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
Genfit’s NIS2+® Endorsed for MASH Detection
Genfit: New EASL-EASD-EASO guidelines include NIS2+
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today